Compare LFST & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LFST | MMSI |
|---|---|---|
| Founded | 2015 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.1B |
| IPO Year | 2021 | 1996 |
| Metric | LFST | MMSI |
|---|---|---|
| Price | $12.27 | $89.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 11 |
| Target Price | $14.40 | ★ $101.64 |
| AVG Volume (30 Days) | ★ 4.0M | 532.4K |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | N/A | ★ 1.33 |
| Revenue | $1,424,285,000.00 | ★ $1,515,906,000.00 |
| Revenue This Year | $19.96 | $7.95 |
| Revenue Next Year | $14.48 | $6.07 |
| P/E Ratio | ★ N/A | $67.47 |
| Revenue Growth | ★ 13.85 | 11.75 |
| 52 Week Low | $4.78 | $59.74 |
| 52 Week High | $14.15 | $94.75 |
| Indicator | LFST | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 59.32 |
| Support Level | $11.76 | $89.13 |
| Resistance Level | $12.97 | $92.22 |
| Average True Range (ATR) | 0.33 | 2.11 |
| MACD | 0.03 | 0.37 |
| Stochastic Oscillator | 65.90 | 83.79 |
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.